Download presentation
Presentation is loading. Please wait.
Published byBeate Christophersen Modified over 5 years ago
1
Conceptual framework of cost-effectiveness of recombinant tissue plasminogen activator (rtPA) therapy. Conceptual framework of cost-effectiveness of recombinant tissue plasminogen activator (rtPA) therapy. ICER, incremental cost-effectiveness analysis; QALY, quality-adjusted life year. Heesoo Joo et al. Stroke Vasc Neurol 2017;2:73-83 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.